nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—hindbrain—brain cancer	0.0367	0.139	CbGeAlD
Auranofin—PRDX5—brainstem—brain cancer	0.021	0.0795	CbGeAlD
Auranofin—PRDX5—telencephalon—brain cancer	0.0186	0.0706	CbGeAlD
Auranofin—PRDX5—gonad—brain cancer	0.0156	0.0589	CbGeAlD
Auranofin—PRDX5—pituitary gland—brain cancer	0.0152	0.0574	CbGeAlD
Auranofin—PRDX5—medulla oblongata—brain cancer	0.0147	0.0554	CbGeAlD
Auranofin—PRDX5—midbrain—brain cancer	0.0134	0.0507	CbGeAlD
Auranofin—PRDX5—spinal cord—brain cancer	0.0131	0.0494	CbGeAlD
Auranofin—PRDX5—endocrine gland—brain cancer	0.0118	0.0445	CbGeAlD
Auranofin—PRDX5—head—brain cancer	0.0116	0.0439	CbGeAlD
Auranofin—Interstitial pneumonia—Temozolomide—brain cancer	0.0113	0.0282	CcSEcCtD
Auranofin—IKBKB—telencephalon—brain cancer	0.011	0.0418	CbGeAlD
Auranofin—PRDX5—central nervous system—brain cancer	0.0106	0.0401	CbGeAlD
Auranofin—PRDX5—cerebellum—brain cancer	0.0104	0.0392	CbGeAlD
Auranofin—IKBKB—gonad—brain cancer	0.00921	0.0349	CbGeAlD
Auranofin—Interstitial pneumonia—Etoposide—brain cancer	0.00903	0.0226	CcSEcCtD
Auranofin—IKBKB—pituitary gland—brain cancer	0.00899	0.034	CbGeAlD
Auranofin—Melaena—Procarbazine—brain cancer	0.00881	0.022	CcSEcCtD
Auranofin—Pancytopenia—Lomustine—brain cancer	0.00847	0.0211	CcSEcCtD
Auranofin—PRDX5—brain—brain cancer	0.00841	0.0318	CbGeAlD
Auranofin—Interstitial lung disease—Carmustine—brain cancer	0.00797	0.0199	CcSEcCtD
Auranofin—Stomatitis—Lomustine—brain cancer	0.00775	0.0193	CcSEcCtD
Auranofin—Interstitial lung disease—Temozolomide—brain cancer	0.00771	0.0192	CcSEcCtD
Auranofin—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00738	0.0184	CcSEcCtD
Auranofin—IKBKB—endocrine gland—brain cancer	0.00696	0.0264	CbGeAlD
Auranofin—Visual impairment—Lomustine—brain cancer	0.00688	0.0172	CcSEcCtD
Auranofin—IKBKB—head—brain cancer	0.00688	0.026	CbGeAlD
Auranofin—Alopecia—Lomustine—brain cancer	0.0063	0.0157	CcSEcCtD
Auranofin—IKBKB—central nervous system—brain cancer	0.00628	0.0237	CbGeAlD
Auranofin—Interstitial lung disease—Etoposide—brain cancer	0.00617	0.0154	CcSEcCtD
Auranofin—IKBKB—cerebellum—brain cancer	0.00613	0.0232	CbGeAlD
Auranofin—Hepatic enzyme increased—Temozolomide—brain cancer	0.00577	0.0144	CcSEcCtD
Auranofin—Dysphagia—Procarbazine—brain cancer	0.00566	0.0141	CcSEcCtD
Auranofin—Eosinophilia—Procarbazine—brain cancer	0.0056	0.014	CcSEcCtD
Auranofin—Leukopenia—Lomustine—brain cancer	0.00556	0.0139	CcSEcCtD
Auranofin—Pancytopenia—Procarbazine—brain cancer	0.00537	0.0134	CcSEcCtD
Auranofin—Aplastic anaemia—Temozolomide—brain cancer	0.00512	0.0128	CcSEcCtD
Auranofin—IKBKB—brain—brain cancer	0.00498	0.0189	CbGeAlD
Auranofin—Thrombocytopenia—Lomustine—brain cancer	0.00496	0.0124	CcSEcCtD
Auranofin—Neuropathy peripheral—Procarbazine—brain cancer	0.00495	0.0124	CcSEcCtD
Auranofin—Stomatitis—Procarbazine—brain cancer	0.00492	0.0123	CcSEcCtD
Auranofin—Jaundice—Procarbazine—brain cancer	0.00492	0.0123	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—SOD2—brain cancer	0.00489	0.0146	CbGpPWpGaD
Auranofin—Anorexia—Lomustine—brain cancer	0.00483	0.0121	CcSEcCtD
Auranofin—Haematuria—Procarbazine—brain cancer	0.00481	0.012	CcSEcCtD
Auranofin—Decreased appetite—Lomustine—brain cancer	0.00441	0.011	CcSEcCtD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—SHH—brain cancer	0.00438	0.0131	CbGpPWpGaD
Auranofin—Dermatitis exfoliative—Temozolomide—brain cancer	0.0042	0.0105	CcSEcCtD
Auranofin—Pancytopenia—Hydroxyurea—brain cancer	0.00416	0.0104	CcSEcCtD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—PTCH1—brain cancer	0.00415	0.0124	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—SMO—brain cancer	0.00415	0.0124	CbGpPWpGaD
Auranofin—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.0041	0.0102	CcSEcCtD
Auranofin—Neutropenia—Hydroxyurea—brain cancer	0.0041	0.0102	CcSEcCtD
Auranofin—IKBKB—NF-kB is activated and signals survival—RELA—brain cancer	0.00401	0.012	CbGpPWpGaD
Auranofin—IKBKB—Osteopontin Signaling—RELA—brain cancer	0.00401	0.012	CbGpPWpGaD
Auranofin—Alopecia—Procarbazine—brain cancer	0.004	0.01	CcSEcCtD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—ABR—brain cancer	0.0039	0.0116	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—CDK4—brain cancer	0.00384	0.0115	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00383	0.00956	CcSEcCtD
Auranofin—Stomatitis—Hydroxyurea—brain cancer	0.00381	0.00951	CcSEcCtD
Auranofin—IKBKB—Atypical NF-kappaB pathway—RELA—brain cancer	0.00378	0.0113	CbGpPWpGaD
Auranofin—IKBKB—FoxO family signaling—SKP2—brain cancer	0.00367	0.0109	CbGpPWpGaD
Auranofin—Anaemia—Procarbazine—brain cancer	0.00364	0.0091	CcSEcCtD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—SHH—brain cancer	0.00358	0.0107	CbGpPWpGaD
Auranofin—Dysphagia—Carmustine—brain cancer	0.00354	0.00884	CcSEcCtD
Auranofin—Leukopenia—Procarbazine—brain cancer	0.00353	0.00882	CcSEcCtD
Auranofin—Dysphagia—Temozolomide—brain cancer	0.00342	0.00855	CcSEcCtD
Auranofin—IKBKB—p75NTR signals via NF-kB—RELA—brain cancer	0.0034	0.0101	CbGpPWpGaD
Auranofin—Pancytopenia—Carmustine—brain cancer	0.00336	0.0084	CcSEcCtD
Auranofin—Neutropenia—Carmustine—brain cancer	0.00331	0.00827	CcSEcCtD
Auranofin—Pancytopenia—Temozolomide—brain cancer	0.00325	0.00812	CcSEcCtD
Auranofin—Vomiting—Lomustine—brain cancer	0.00322	0.00805	CcSEcCtD
Auranofin—Neutropenia—Temozolomide—brain cancer	0.0032	0.00799	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—NTRK3—brain cancer	0.00317	0.00946	CbGpPWpGaD
Auranofin—Thrombocytopenia—Procarbazine—brain cancer	0.00315	0.00787	CcSEcCtD
Auranofin—Alopecia—Hydroxyurea—brain cancer	0.0031	0.00774	CcSEcCtD
Auranofin—Weight decreased—Temozolomide—brain cancer	0.0031	0.00773	CcSEcCtD
Auranofin—Neuropathy peripheral—Carmustine—brain cancer	0.00309	0.00773	CcSEcCtD
Auranofin—Stomatitis—Carmustine—brain cancer	0.00308	0.00769	CcSEcCtD
Auranofin—Anorexia—Procarbazine—brain cancer	0.00307	0.00766	CcSEcCtD
Auranofin—Nausea—Lomustine—brain cancer	0.00301	0.00752	CcSEcCtD
Auranofin—Neuropathy peripheral—Temozolomide—brain cancer	0.00299	0.00747	CcSEcCtD
Auranofin—Stomatitis—Temozolomide—brain cancer	0.00297	0.00743	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—CDKN2A—brain cancer	0.00294	0.00876	CbGpPWpGaD
Auranofin—ALB—brain—brain cancer	0.00291	0.011	CbGeAlD
Auranofin—PRDX5—Cellular responses to stress—RELA—brain cancer	0.00283	0.00843	CbGpPWpGaD
Auranofin—Anaemia—Hydroxyurea—brain cancer	0.00282	0.00704	CcSEcCtD
Auranofin—Decreased appetite—Procarbazine—brain cancer	0.0028	0.00699	CcSEcCtD
Auranofin—Constipation—Procarbazine—brain cancer	0.00275	0.00687	CcSEcCtD
Auranofin—Dysphagia—Etoposide—brain cancer	0.00274	0.00684	CcSEcCtD
Auranofin—IKBKB—RIP-mediated NFkB activation via ZBP1—RELA—brain cancer	0.00273	0.00815	CbGpPWpGaD
Auranofin—Leukopenia—Hydroxyurea—brain cancer	0.00273	0.00682	CcSEcCtD
Auranofin—Visual impairment—Carmustine—brain cancer	0.00273	0.00682	CcSEcCtD
Auranofin—Eye disorder—Carmustine—brain cancer	0.00265	0.00661	CcSEcCtD
Auranofin—Visual impairment—Temozolomide—brain cancer	0.00264	0.00659	CcSEcCtD
Auranofin—Gastrointestinal pain—Procarbazine—brain cancer	0.00263	0.00657	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—VAV1—brain cancer	0.00263	0.00783	CbGpPWpGaD
Auranofin—Pancytopenia—Etoposide—brain cancer	0.0026	0.00649	CcSEcCtD
Auranofin—IKBKB—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.0026	0.00775	CbGpPWpGaD
Auranofin—Neutropenia—Etoposide—brain cancer	0.00256	0.00639	CcSEcCtD
Auranofin—Eye disorder—Temozolomide—brain cancer	0.00256	0.00639	CcSEcCtD
Auranofin—Urticaria—Procarbazine—brain cancer	0.00256	0.00639	CcSEcCtD
Auranofin—Abdominal pain—Procarbazine—brain cancer	0.00254	0.00635	CcSEcCtD
Auranofin—IKBKB—EBV LMP1 signaling—RELA—brain cancer	0.00254	0.00758	CbGpPWpGaD
Auranofin—IKBKB—Canonical NF-kappaB pathway—RELA—brain cancer	0.00254	0.00758	CbGpPWpGaD
Auranofin—IKBKB—FCERI mediated NF-kB activation—RELA—brain cancer	0.00254	0.00758	CbGpPWpGaD
Auranofin—Alopecia—Carmustine—brain cancer	0.0025	0.00625	CcSEcCtD
Auranofin—IKBKB—FoxO family signaling—SIRT1—brain cancer	0.00249	0.00744	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated NF-kB activation—RELA—brain cancer	0.00246	0.00732	CbGpPWpGaD
Auranofin—Thrombocytopenia—Hydroxyurea—brain cancer	0.00244	0.00609	CcSEcCtD
Auranofin—Alopecia—Temozolomide—brain cancer	0.00242	0.00604	CcSEcCtD
Auranofin—IKBKB—FoxO family signaling—SOD2—brain cancer	0.0024	0.00716	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Etoposide—brain cancer	0.00239	0.00598	CcSEcCtD
Auranofin—Jaundice—Etoposide—brain cancer	0.00238	0.00594	CcSEcCtD
Auranofin—Stomatitis—Etoposide—brain cancer	0.00238	0.00594	CcSEcCtD
Auranofin—Anorexia—Hydroxyurea—brain cancer	0.00237	0.00593	CcSEcCtD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—VAV1—brain cancer	0.00235	0.007	CbGpPWpGaD
Auranofin—Dysgeusia—Temozolomide—brain cancer	0.00233	0.00583	CcSEcCtD
Auranofin—IKBKB—ZBP1(DAI) mediated induction of type I IFNs—RELA—brain cancer	0.0023	0.00687	CbGpPWpGaD
Auranofin—IKBKB—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—RELA—brain cancer	0.0023	0.00687	CbGpPWpGaD
Auranofin—Anaemia—Carmustine—brain cancer	0.00228	0.00569	CcSEcCtD
Auranofin—Agranulocytosis—Etoposide—brain cancer	0.00228	0.00569	CcSEcCtD
Auranofin—Pruritus—Procarbazine—brain cancer	0.00228	0.00569	CcSEcCtD
Auranofin—Leukopenia—Carmustine—brain cancer	0.00221	0.00552	CcSEcCtD
Auranofin—Anaemia—Temozolomide—brain cancer	0.0022	0.0055	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—VAV1—brain cancer	0.0022	0.00657	CbGpPWpGaD
Auranofin—Diarrhoea—Procarbazine—brain cancer	0.0022	0.0055	CcSEcCtD
Auranofin—Dyspepsia—Hydroxyurea—brain cancer	0.00219	0.00548	CcSEcCtD
Auranofin—Angioedema—Temozolomide—brain cancer	0.00218	0.00544	CcSEcCtD
Auranofin—Decreased appetite—Hydroxyurea—brain cancer	0.00217	0.00541	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—VEGFA—brain cancer	0.00216	0.00645	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—STAT3—brain cancer	0.00214	0.00639	CbGpPWpGaD
Auranofin—Leukopenia—Temozolomide—brain cancer	0.00213	0.00533	CcSEcCtD
Auranofin—Constipation—Hydroxyurea—brain cancer	0.00213	0.00532	CcSEcCtD
Auranofin—Eye disorder—Etoposide—brain cancer	0.00205	0.00511	CcSEcCtD
Auranofin—Vomiting—Procarbazine—brain cancer	0.00205	0.00511	CcSEcCtD
Auranofin—Rash—Procarbazine—brain cancer	0.00203	0.00507	CcSEcCtD
Auranofin—Dermatitis—Procarbazine—brain cancer	0.00203	0.00506	CcSEcCtD
Auranofin—IKBKB—IL17 signaling pathway—RELA—brain cancer	0.002	0.00597	CbGpPWpGaD
Auranofin—Thrombocytopenia—Carmustine—brain cancer	0.00197	0.00492	CcSEcCtD
Auranofin—IKBKB—mTOR signaling pathway—CCNE1—brain cancer	0.00194	0.00579	CbGpPWpGaD
Auranofin—Alopecia—Etoposide—brain cancer	0.00194	0.00484	CcSEcCtD
Auranofin—Anorexia—Carmustine—brain cancer	0.00192	0.00479	CcSEcCtD
Auranofin—Nausea—Procarbazine—brain cancer	0.00191	0.00477	CcSEcCtD
Auranofin—Thrombocytopenia—Temozolomide—brain cancer	0.00191	0.00476	CcSEcCtD
Auranofin—Dysgeusia—Etoposide—brain cancer	0.00187	0.00467	CcSEcCtD
Auranofin—IKBKB—IL-4 Signaling Pathway—IRS2—brain cancer	0.00186	0.00555	CbGpPWpGaD
Auranofin—IKBKB—IL1-mediated signaling events—RELA—brain cancer	0.00186	0.00554	CbGpPWpGaD
Auranofin—Anorexia—Temozolomide—brain cancer	0.00185	0.00463	CcSEcCtD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—VAV1—brain cancer	0.00185	0.00552	CbGpPWpGaD
Auranofin—Anaemia—Etoposide—brain cancer	0.00176	0.0044	CcSEcCtD
Auranofin—Decreased appetite—Carmustine—brain cancer	0.00175	0.00437	CcSEcCtD
Auranofin—Constipation—Carmustine—brain cancer	0.00172	0.0043	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—VAV1—brain cancer	0.00172	0.00513	CbGpPWpGaD
Auranofin—Dyspepsia—Temozolomide—brain cancer	0.00171	0.00428	CcSEcCtD
Auranofin—Leukopenia—Etoposide—brain cancer	0.00171	0.00426	CcSEcCtD
Auranofin—Diarrhoea—Hydroxyurea—brain cancer	0.0017	0.00426	CcSEcCtD
Auranofin—Decreased appetite—Temozolomide—brain cancer	0.00169	0.00422	CcSEcCtD
Auranofin—Constipation—Temozolomide—brain cancer	0.00166	0.00416	CcSEcCtD
Auranofin—Gastrointestinal pain—Carmustine—brain cancer	0.00165	0.00411	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—TP53—brain cancer	0.00163	0.00487	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—VAV1—brain cancer	0.00162	0.00483	CbGpPWpGaD
Auranofin—IKBKB—Downstream TCR signaling—RELA—brain cancer	0.0016	0.00477	CbGpPWpGaD
Auranofin—IKBKB—NOD pathway—RELA—brain cancer	0.0016	0.00477	CbGpPWpGaD
Auranofin—Abdominal pain—Carmustine—brain cancer	0.00159	0.00398	CcSEcCtD
Auranofin—Gastrointestinal pain—Temozolomide—brain cancer	0.00159	0.00397	CcSEcCtD
Auranofin—Vomiting—Hydroxyurea—brain cancer	0.00158	0.00396	CcSEcCtD
Auranofin—Rash—Hydroxyurea—brain cancer	0.00157	0.00392	CcSEcCtD
Auranofin—IKBKB—TWEAK Signaling Pathway—RELA—brain cancer	0.00157	0.00468	CbGpPWpGaD
Auranofin—Dermatitis—Hydroxyurea—brain cancer	0.00157	0.00392	CcSEcCtD
Auranofin—Urticaria—Temozolomide—brain cancer	0.00155	0.00386	CcSEcCtD
Auranofin—Abdominal pain—Temozolomide—brain cancer	0.00154	0.00384	CcSEcCtD
Auranofin—Thrombocytopenia—Etoposide—brain cancer	0.00152	0.00381	CcSEcCtD
Auranofin—IKBKB—IL17 signaling pathway—STAT3—brain cancer	0.00152	0.00452	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—RELA—brain cancer	0.00151	0.00451	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—VAV1—brain cancer	0.00149	0.00443	CbGpPWpGaD
Auranofin—Anorexia—Etoposide—brain cancer	0.00148	0.00371	CcSEcCtD
Auranofin—Nausea—Hydroxyurea—brain cancer	0.00148	0.00369	CcSEcCtD
Auranofin—IKBKB—TNF receptor signaling pathway —RELA—brain cancer	0.00146	0.00435	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ABR—brain cancer	0.00144	0.00429	CbGpPWpGaD
Auranofin—IKBKB—Structural Pathway of Interleukin 1 (IL-1)—RELA—brain cancer	0.00143	0.00428	CbGpPWpGaD
Auranofin—Diarrhoea—Carmustine—brain cancer	0.00138	0.00344	CcSEcCtD
Auranofin—Pruritus—Temozolomide—brain cancer	0.00138	0.00344	CcSEcCtD
Auranofin—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RELA—brain cancer	0.00136	0.00407	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—CTNNB1—brain cancer	0.00136	0.00407	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—CTNNB1—brain cancer	0.00136	0.00407	CbGpPWpGaD
Auranofin—Decreased appetite—Etoposide—brain cancer	0.00135	0.00338	CcSEcCtD
Auranofin—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.00133	0.00398	CbGpPWpGaD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—CDKN2A—brain cancer	0.00133	0.00398	CbGpPWpGaD
Auranofin—Constipation—Etoposide—brain cancer	0.00133	0.00333	CcSEcCtD
Auranofin—Diarrhoea—Temozolomide—brain cancer	0.00133	0.00332	CcSEcCtD
Auranofin—IKBKB—GMCSF-mediated signaling events—STAT3—brain cancer	0.00132	0.00392	CbGpPWpGaD
Auranofin—IKBKB—IL-4 Signaling Pathway—RELA—brain cancer	0.00128	0.00383	CbGpPWpGaD
Auranofin—Vomiting—Carmustine—brain cancer	0.00128	0.0032	CcSEcCtD
Auranofin—Gastrointestinal pain—Etoposide—brain cancer	0.00127	0.00318	CcSEcCtD
Auranofin—Rash—Carmustine—brain cancer	0.00127	0.00317	CcSEcCtD
Auranofin—Dermatitis—Carmustine—brain cancer	0.00127	0.00317	CcSEcCtD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—RELA—brain cancer	0.00126	0.00377	CbGpPWpGaD
Auranofin—IKBKB—IL-1 signaling pathway—RELA—brain cancer	0.00126	0.00377	CbGpPWpGaD
Auranofin—Vomiting—Temozolomide—brain cancer	0.00124	0.00309	CcSEcCtD
Auranofin—Urticaria—Etoposide—brain cancer	0.00124	0.00309	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—SPP1—brain cancer	0.00124	0.00369	CbGpPWpGaD
Auranofin—Abdominal pain—Etoposide—brain cancer	0.00123	0.00307	CcSEcCtD
Auranofin—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.00123	0.00366	CbGpPWpGaD
Auranofin—Rash—Temozolomide—brain cancer	0.00123	0.00306	CcSEcCtD
Auranofin—Dermatitis—Temozolomide—brain cancer	0.00123	0.00306	CcSEcCtD
Auranofin—IKBKB—FoxO family signaling—CTNNB1—brain cancer	0.00121	0.0036	CbGpPWpGaD
Auranofin—Nausea—Carmustine—brain cancer	0.0012	0.00299	CcSEcCtD
Auranofin—IKBKB—TCR signaling—RELA—brain cancer	0.0012	0.00357	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—RELA—brain cancer	0.00116	0.00347	CbGpPWpGaD
Auranofin—Nausea—Temozolomide—brain cancer	0.00116	0.00289	CcSEcCtD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—PIK3CG—brain cancer	0.00115	0.00344	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—STAT3—brain cancer	0.00115	0.00342	CbGpPWpGaD
Auranofin—IKBKB—Activation of NF-kappaB in B cells—RELA—brain cancer	0.00111	0.0033	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—MYC—brain cancer	0.0011	0.0033	CbGpPWpGaD
Auranofin—Pruritus—Etoposide—brain cancer	0.0011	0.00275	CcSEcCtD
Auranofin—IKBKB—AGE/RAGE pathway—RELA—brain cancer	0.00109	0.00326	CbGpPWpGaD
Auranofin—IKBKB—Cytosolic sensors of pathogen-associated DNA—RELA—brain cancer	0.00109	0.00326	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—brain cancer	0.00108	0.00322	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—RELA—brain cancer	0.00108	0.00322	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—RELA—brain cancer	0.00108	0.00322	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—brain cancer	0.00107	0.0032	CbGpPWpGaD
Auranofin—Diarrhoea—Etoposide—brain cancer	0.00107	0.00266	CcSEcCtD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—VAV1—brain cancer	0.00105	0.00313	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—PIK3CG—brain cancer	0.00103	0.00307	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—VAV1—brain cancer	0.001	0.00298	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—SOD2—brain cancer	0.000999	0.00298	CbGpPWpGaD
Auranofin—Vomiting—Etoposide—brain cancer	0.00099	0.00247	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—PIK3CG—brain cancer	0.000987	0.00294	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—brain cancer	0.000987	0.00294	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—RELA—brain cancer	0.000987	0.00294	CbGpPWpGaD
Auranofin—Rash—Etoposide—brain cancer	0.000982	0.00245	CcSEcCtD
Auranofin—Dermatitis—Etoposide—brain cancer	0.000981	0.00245	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—ERBB2—brain cancer	0.000981	0.00292	CbGpPWpGaD
Auranofin—IKBKB—IL-4 Signaling Pathway—STAT3—brain cancer	0.000973	0.0029	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—SPP1—brain cancer	0.000965	0.00288	CbGpPWpGaD
Auranofin—IKBKB—Cytosolic sensors of pathogen-associated DNA—CTNNB1—brain cancer	0.00095	0.00283	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—brain cancer	0.000939	0.0028	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—SPP1—brain cancer	0.000938	0.0028	CbGpPWpGaD
Auranofin—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—RELA—brain cancer	0.000937	0.00279	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—CDKN2A—brain cancer	0.000936	0.00279	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—VAV1—brain cancer	0.000926	0.00276	CbGpPWpGaD
Auranofin—Nausea—Etoposide—brain cancer	0.000925	0.00231	CcSEcCtD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—RELA—brain cancer	0.000919	0.00274	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—RELA—brain cancer	0.000901	0.00269	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—RELA—brain cancer	0.000893	0.00266	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—brain cancer	0.000884	0.00264	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CDKN2A—brain cancer	0.000878	0.00262	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—RELA—brain cancer	0.000868	0.00259	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—CCND1—brain cancer	0.000866	0.00258	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PDGFRA—brain cancer	0.000858	0.00256	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—RELA—brain cancer	0.000853	0.00254	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—IRS2—brain cancer	0.000848	0.00253	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—RELA—brain cancer	0.000838	0.0025	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—STAT3—brain cancer	0.000828	0.00247	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—RELA—brain cancer	0.000824	0.00246	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PDGFRA—brain cancer	0.000819	0.00244	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—STAT3—brain cancer	0.000818	0.00244	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—RELA—brain cancer	0.000803	0.0024	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—SOD2—brain cancer	0.000794	0.00237	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—RELA—brain cancer	0.00079	0.00236	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—brain cancer	0.000784	0.00234	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—IRS2—brain cancer	0.00078	0.00233	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—RELA—brain cancer	0.000772	0.0023	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—PIK3CG—brain cancer	0.000771	0.0023	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—MYC—brain cancer	0.00076	0.00227	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PDGFRA—brain cancer	0.000758	0.00226	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—IRS2—brain cancer	0.000754	0.00225	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—EGFR—brain cancer	0.000753	0.00225	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—APC—brain cancer	0.000749	0.00223	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—STAT3—brain cancer	0.000748	0.00223	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—EGFR—brain cancer	0.000744	0.00222	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—RELA—brain cancer	0.000737	0.0022	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IRS2—brain cancer	0.000719	0.00215	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—RELA—brain cancer	0.000711	0.00212	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—RELA—brain cancer	0.00071	0.00212	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—VAV1—brain cancer	0.000693	0.00207	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—PIK3CG—brain cancer	0.000689	0.00205	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MPL—brain cancer	0.000688	0.00205	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—STAT3—brain cancer	0.000683	0.00204	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—VAV1—brain cancer	0.000682	0.00203	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—RELA—brain cancer	0.000669	0.00199	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—IRS2—brain cancer	0.000666	0.00199	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL2—brain cancer	0.000664	0.00198	CbGpPWpGaD
Auranofin—ALB—Hemostasis—S100A10—brain cancer	0.00066	0.00197	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—MYC—brain cancer	0.000635	0.00189	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—brain cancer	0.000625	0.00186	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—OR14C36—brain cancer	0.00061	0.00182	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—OR4C12—brain cancer	0.00061	0.00182	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—TP53—brain cancer	0.00061	0.00182	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—RELA—brain cancer	0.000602	0.0018	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—RELA—brain cancer	0.000595	0.00178	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000591	0.00176	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—RELA—brain cancer	0.000586	0.00175	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—RELA—brain cancer	0.000578	0.00172	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	0.000571	0.0017	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—MYC—brain cancer	0.000566	0.00169	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—STAT3—brain cancer	0.000559	0.00167	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PDGFRA—brain cancer	0.000558	0.00166	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TP53—brain cancer	0.000521	0.00155	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL2—brain cancer	0.00052	0.00155	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—RELA—brain cancer	0.00052	0.00155	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DTX2—brain cancer	0.000519	0.00155	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—brain cancer	0.000517	0.00154	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—CTNNB1—brain cancer	0.000509	0.00152	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IRS2—brain cancer	0.000498	0.00149	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000498	0.00148	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—RELA—brain cancer	0.000496	0.00148	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—ERBB2—brain cancer	0.000493	0.00147	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IRS2—brain cancer	0.00049	0.00146	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—SKP2—brain cancer	0.00049	0.00146	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TP53—brain cancer	0.000489	0.00146	CbGpPWpGaD
Auranofin—ALB—Hemostasis—BSG—brain cancer	0.000465	0.00139	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—RELA—brain cancer	0.000459	0.00137	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—RELA—brain cancer	0.000459	0.00137	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—ERBB2—brain cancer	0.000457	0.00136	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—STAT3—brain cancer	0.000444	0.00132	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000443	0.00132	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTCH2—brain cancer	0.000393	0.00117	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—VAV1—brain cancer	0.000389	0.00116	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HES5—brain cancer	0.000381	0.00114	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—VEGFA—brain cancer	0.000379	0.00113	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—VAV1—brain cancer	0.000373	0.00111	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STRADA—brain cancer	0.00037	0.0011	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MYC—brain cancer	0.000364	0.00109	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000364	0.00108	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	0.000361	0.00108	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—brain cancer	0.000358	0.00107	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—EGFR—brain cancer	0.000357	0.00106	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—RELA—brain cancer	0.000344	0.00103	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	0.000342	0.00102	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—RELA—brain cancer	0.000338	0.00101	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ERBB2—brain cancer	0.000336	0.001	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—brain cancer	0.000334	0.000996	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PDGFRA—brain cancer	0.000318	0.000949	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—EGFR—brain cancer	0.000316	0.000944	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL2—brain cancer	0.00031	0.000924	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ABR—brain cancer	0.000309	0.00092	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PDGFRA—brain cancer	0.000306	0.000912	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TRPC6—brain cancer	0.000305	0.000908	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—brain cancer	0.000299	0.000893	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GLI2—brain cancer	0.000298	0.000889	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SKP2—brain cancer	0.000297	0.000886	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000281	0.000838	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GLI1—brain cancer	0.00028	0.000836	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IRS2—brain cancer	0.00028	0.000834	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—IRS2—brain cancer	0.000268	0.0008	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SUFU—brain cancer	0.000266	0.000792	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000264	0.000786	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—STAT3—brain cancer	0.000261	0.000777	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GFAP—brain cancer	0.000256	0.000764	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—STAT3—brain cancer	0.000256	0.000764	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HEY1—brain cancer	0.000243	0.000725	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—DLL1—brain cancer	0.000238	0.000711	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGFR—brain cancer	0.000233	0.000695	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VAV1—brain cancer	0.000228	0.000681	CbGpPWpGaD
Auranofin—IKBKB—Immune System—VAV1—brain cancer	0.000226	0.000675	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP2C9—brain cancer	0.000222	0.000661	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SHH—brain cancer	0.000203	0.000604	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	0.000198	0.00059	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TRPC6—brain cancer	0.000195	0.000583	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—RELA—brain cancer	0.000193	0.000575	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SMO—brain cancer	0.000192	0.000573	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTCH1—brain cancer	0.000192	0.000573	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ERBB2—brain cancer	0.000192	0.000572	CbGpPWpGaD
Auranofin—ALB—Metabolism—BSG—brain cancer	0.000188	0.000562	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PDGFRA—brain cancer	0.000185	0.000553	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—RELA—brain cancer	0.000185	0.000552	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ERBB2—brain cancer	0.000184	0.000549	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	0.000168	0.000501	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CTNNB1—brain cancer	0.000168	0.0005	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRS2—brain cancer	0.000163	0.000485	CbGpPWpGaD
Auranofin—ALB—Metabolism—IDH1—brain cancer	0.000162	0.000483	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOTCH2—brain cancer	0.000154	0.000458	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VAV1—brain cancer	0.000146	0.000437	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CG—brain cancer	0.000145	0.000432	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGFR—brain cancer	0.000133	0.000396	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000132	0.000393	CbGpPWpGaD
Auranofin—ALB—Metabolism—ENO2—brain cancer	0.000128	0.000382	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGFR—brain cancer	0.000128	0.00038	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HES1—brain cancer	0.000126	0.000375	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDGFRA—brain cancer	0.00012	0.000358	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SPP1—brain cancer	0.000116	0.000347	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RELA—brain cancer	0.000112	0.000335	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB2—brain cancer	0.000112	0.000333	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IRS2—brain cancer	0.000105	0.000314	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—brain cancer	0.000102	0.000304	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—brain cancer	0.000101	0.000302	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTNNB1—brain cancer	9.77e-05	0.000291	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APC—brain cancer	9.3e-05	0.000277	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CG—brain cancer	9.3e-05	0.000277	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—brain cancer	8.67e-05	0.000258	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT3—brain cancer	8.51e-05	0.000254	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGFR—brain cancer	7.74e-05	0.000231	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RELA—brain cancer	7.26e-05	0.000217	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB2—brain cancer	7.22e-05	0.000215	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—brain cancer	6.55e-05	0.000195	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—brain cancer	6.54e-05	0.000195	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—brain cancer	6.38e-05	0.00019	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CTNNB1—brain cancer	6.31e-05	0.000188	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CG—brain cancer	5.88e-05	0.000175	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—brain cancer	5.56e-05	0.000166	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT3—brain cancer	5.5e-05	0.000164	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—brain cancer	5.11e-05	0.000153	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGFR—brain cancer	5e-05	0.000149	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—brain cancer	4.2e-05	0.000125	CbGpPWpGaD
